Cargando…
TRAF2 is an NF-κB activating oncogene in epithelial cancers
Aberrant NF-κB activation is frequently observed in human cancers. Genome characterization efforts have identified genetic alterations in multiple components of the NF-κB pathway, some of which have been shown to be essential for cancer initiation and tumor maintenance. Here using patient tumors and...
Autores principales: | Shen, Rhine R., Zhou, Alicia Y., Kim, Eejung, O’Connell, Joyce T., Hagerstrand, Daniel, Beroukhim, Rameen, Hahn, William C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067463/ https://www.ncbi.nlm.nih.gov/pubmed/24362534 http://dx.doi.org/10.1038/onc.2013.543 |
Ejemplares similares
-
The TRAF6-NFκB signaling pathway in autoimmunity: not just inflammation
por: Thomas, Ranjeny
Publicado: (2005) -
SHARPIN Negatively Associates with TRAF2-Mediated NFκB Activation
por: Liang, Yanhua
Publicado: (2011) -
EI24 regulates epithelial-to-mesenchymal transition and tumor progression by suppressing TRAF2-mediated NF-κB activity
por: Choi, Jung-Min, et al.
Publicado: (2013) -
Rescue of TRAF3-null mice by p100 NF-κB deficiency
por: He, Jeannie Q., et al.
Publicado: (2006) -
TRAF6 neddylation drives inflammatory arthritis by increasing NF-κB activation
por: Liu, Kewei, et al.
Publicado: (2019)